Jason C. Jones - 07 Apr 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
VP of Product Development
Signature
/s/ Jerome Wong, as attorney-in-fact
Issuer symbol
EKSO
Transactions as of
07 Apr 2022
Transactions value $
$0
Form type
4
Filing time
11 Apr 2022, 18:10:55 UTC
Previous filing
28 Mar 2022
Next filing
02 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +50K +61.25% $0.00 132K 07 Apr 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs").
F2 The grant of RSUs was approved by the Compensation Committee of the Board of Directors on April 7, 2022.
F3 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022.